Literature DB >> 2186669

High Staphylococcus aureus nasal carriage rate in patients with acquired immunodeficiency syndrome or AIDS-related complex.

M C Raviglione1, P Mariuz, A Pablos-Mendez, R Battan, P Ottuso, A Taranta.   

Abstract

Staphylococcus aureus has been reported to cause a high number of infections and septicemias, often related to intravenous catheters, in patients with acquired immunodeficiency syndrome (AIDS). Our objective was to assess the frequency of S. aureus nasal carriage among patients with AIDS or AIDS-related complex (ARC). The nasal carriage rate of S. aureus was determined within 24 hours of admission in 64 consecutively hospitalized patients with AIDS or ARC. Intravenous drug abusers were excluded. A control group of 64 patients with other diseases was also tested. Of 64 patients with AIDS or ARC, 35 (55%) were nasal carriers of S. aureus, compared with 18 (28%) of 64 control patients. Recent hospitalization did not influence carriage rate, nor did the recent use of antibiotics or zidovudine. The significant S. aureus carriage rate in patients with AIDS or ARC may contribute to the high incidence of intravenous catheter-related S. aureus infections in this population.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2186669     DOI: 10.1016/0196-6553(90)90083-5

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  11 in total

Review 1.  Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks.

Authors:  J Kluytmans; A van Belkum; H Verbrugh
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital.

Authors:  M C Raviglione; J F Boyle; P Mariuz; A Pablos-Mendez; H Cortes; A Merlo
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  Phenotypic and genotypic characterization of nosocomial Staphylococcus aureus isolates from trauma patients.

Authors:  T Na'was; A Hawwari; E Hendrix; J Hebden; R Edelman; M Martin; W Campbell; R Naso; R Schwalbe; A I Fattom
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

4.  Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment].

Authors:  S Takei; Y K Arora; S M Walker
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

5.  Activation of the human immunodeficiency virus long terminal repeat in THP-1 cells by a staphylococcal extracellular product.

Authors:  S J Klebanoff; F Kazazi; W C Van Voorhis; K G Schlechte
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

6.  Cutaneous microenvironment of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative individuals, with special reference to Staphylococcus aureus colonization.

Authors:  M Shapiro; K J Smith; W D James; W J Giblin; D J Margolis; A N Foglia; K McGinley; J J Leyden
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

7.  Staphylococcal Panton-Valentine leucocidin as a major virulence factor associated to furuncles.

Authors:  Lamine Baba-Moussa; Haziz Sina; Jean-Michel Scheftel; Brigitte Moreau; Dominique Sainte-Marie; Simeon O Kotchoni; Gilles Prévost; Pierre Couppié
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

8.  Methicillin-resistant Staphylococcus aureus in HIV-infected patients.

Authors:  Alicia I Hidron; Russell Kempker; Abeer Moanna; David Rimland
Journal:  Infect Drug Resist       Date:  2010-08-06       Impact factor: 4.003

9.  Antibiotic sensitivity pattern of Staphylococcus aureus from clinical isolates in a tertiary health institution in Kano, Northwestern Nigeria.

Authors:  Emmanuel Onwubiko Nwankwo; Magaji Sadiq Nasiru
Journal:  Pan Afr Med J       Date:  2011-01-26

Review 10.  Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections.

Authors:  Adèle Sakr; Fabienne Brégeon; Jean-Louis Mège; Jean-Marc Rolain; Olivier Blin
Journal:  Front Microbiol       Date:  2018-10-08       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.